JNJ-8003
JNJ-8003 is a potent and orally active non-nucleoside RSV polymerase inhibitor with an IC50 of 0.29 nM. JNJ-8003 targets the L protein polymerase complex of RSV (IC50 = 0.67 nM), and blocks the transcription and replication of the viral genome by inhibiting the activity of RNA-dependent RNA polymerase (RdRp) . JNJ-8003 displays subnanomolar activity in vitro as well as prominent efficacy in mice and a neonatal lamb models. JNJ-8003 can be used for the study of respiratory syncytial virus (RSV) [1][2].
Product Specifications
UNSPSC
12352005
Target
DNA/RNA Synthesis; RSV
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/jnj-8003.html
Purity
99.84
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
CC(N=N1)=CC2=C1C(OC)=CC(C(NC[C@](C(F)(F)F)(O)C3=CC(C(C)(C)O)=C(F)C(C4=CC=C(F)C=C4)=N3)=O)=C2
Molecular Formula
C28H25F5N4O4
Molecular Weight
576.51
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti Human CD36 Flow Cytometry Monoclonal Clone 5271 APC Ready To Use 100 Tests
Lentiviral human TREX2 shRNA (UAS) - Lentiviral human TREX2 shRNA (UAS, RFP) (25)
![Recombinant Oryza sativa subsp. japonica Acyl-[acyl-carrier-protein] desaturase 7, chloroplastic (Os08g0200100, LOC_Os08g10010)](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
Recombinant Oryza sativa subsp. japonica Acyl-[acyl-carrier-protein] desaturase 7, chloroplastic (Os08g0200100, LOC_Os08g10010)
Recombinant Oryza sativa subsp. japonica Acyl-[acyl-carrier-protein] desaturase 7, chloroplastic (Os08g0200100, LOC_Os08g10010)
Recombinant Oryza sativa subsp. japonica Acyl-[acyl-carrier-protein] desaturase 7, chloroplastic (Os08g0200100, LOC_Os08g10010)